About Our Company

How We Help Patients

skin cancer, is the most common cancer in the United States and worldwide.

• 1 in 5 Americans will develop skin cancer by the age of 70.
• More than 2 people die of skin cancer in the U.S. every hour.
• Having 5 or more sunburns doubles your risk for melanoma.
• When detected early, the 5-year survival rate for melanoma is 99 percent.

https://www.skincancer.org/skin-cancer-information/skin-cancer-facts/

We will provide people with a free app that enables early detection of melanoma and aims to reduce melanoma-related deaths by 90%.

How We Help Physicians

We understand that dermatologists around the world are overwhelmed. Although you strive to help as many people as possible, your capacity is limited, and your waiting lists are often filled with trivial cases that could be handled offline. It’s completely understandable to feel frustrated when a patient visits you with late-stage melanoma, and all you can do is fight a losing battle against skin cancer.

We also recognize that diagnosing skin lesions can be very challenging. Just the other day, I spoke with a dermatologist who showed me a photo of a lesion. She thought it was seborrheic keratosis but wasn’t completely sure. After using our app, which indicated a high-risk lesion, she said, “Yeah, I’m not certain, but maybe the top right corner is starting to show melanoma, so I recommended having it removed.”

Having a second diagnostic opinion can help improve your accuracy, save more lives, and prevent unnecessary procedures for some patients.

AI accuracy:

• https://medium.com/@attilaulbert/performance-of-the-regular-ai-of-emdee-skin-c7df6cf9e610
• https://medium.com/@attilaulbert/the-performance-of-the-dermoscopic-ai-of-emdee-ai-4adb8e7ee6f7

How We Help Hospitals

We understand that dermatology clinics worldwide are overwhelmed with demand. While clinics strive to serve as many patients as possible, your resources are limited, and your waiting lists are often filled with routine cases that could be managed remotely. This limits your ability to prioritize in-person visits for cases that truly require it, such as those needing surgical intervention.

Costs escalate dramatically, and cases become more severe and complex when patients arrive with advanced-stage melanoma—turning what could have been a straightforward, early-stage operation into a difficult and often losing battle against skin cancer.

We also recognize the challenges dermatologists face when diagnosing ambiguous cases. Recently, I spoke with a dermatologist who shared a photo of a lesion she suspected might be seborrheic keratosis but wasn’t certain. After using our app, which flagged the lesion as high-risk, she decided to have it removed, suspecting early melanoma in a small area. This kind of second opinion tool can improve diagnostic accuracy, save more lives, and prevent unnecessary surgeries for benign conditions.

The emdee skin app, together with the Physician Console, helps prioritize patients and supports your dermatologists in making more precise diagnoses, ultimately enhancing patient care and clinic efficiency.

References:

• https://medium.com/@attilaulbert/performance-of-the-regular-ai-of-emdee-skin-c7df6cf9e610
• https://medium.com/@attilaulbert/the-performance-of-the-dermoscopic-ai-of-emdee-ai-4adb8e7ee6f7

How We Help Partners

We help skincare product manufacturers connect with the right audience. Our users are health-conscious and highly interested in quality skincare products. We educate them on protecting their skin from UV radiation. If you’re looking for a platform to promote your sunscreen cream, Emdee Skin is the perfect choice.

Innovation Details

Intellectual Property Summary

The AI IP is shared between ELTE and emdee.ai. The IP of the rest of the system belongs to the emdee.ai team: Attila Ulbert, Ferenc Kovacs, Tibor Kecskemeti, Gabor Koszo, Mate Lebedy.

To clarify the above selection: while I have disclosed certain technical aspects of the AI, I intend to keep the core technical details proprietary as trade secrets.

Clinical Information

We have two posts descrbing the efficiency of the AI:

https://medium.com/@attilaulbert/performance-of-the-regular-ai-of-emdee-skin-c7df6cf9e610

https://medium.com/@attilaulbert/the-performance-of-the-dermoscopic-ai-of-emdee-ai-4adb8e7ee6f7

Regulatory Status

We need EU MDR registration and FDA approval. This is our immadiate next task to complete, and we seek founding for this as a minimum.

Also, we have to comply with the EU AI Act, since the emdee AI is a high-risk AI system per EU regulation.

How we will use the funds raised

First and foremost, our priority is to obtain clearance under the EU MDR, FDA, and the EU AI Act.

Following that, in alignment with our mission, we aim to develop a healthcare content aggregation feature within the app. Initially, this will focus on dermatology-related content—such as articles, posts, and research papers—customized to each user. The goal is to educate users on dermatology and general healthcare topics while keeping the app free by delivering relevant advertisements (e.g., for sunscreen).

Thank You

I’ve lost many family members and classmates to melanoma, and I myself may be at risk. But it shouldn't have to be this way. All of them might still be alive today if their malignant skin lesions had been detected earlier. When diagnosed in its early stages, melanoma-related deaths are 99% preventable.

That’s why I developed emdee AI, in collaboration with the Dermatology Clinic of Semmelweis Medical University — to help reduce melanoma-related deaths by 90%.

The emdee Skin app is completely free, because we believe that saving lives should never depend on someone’s ability to pay. Without free access, we cannot reach our goal.

In early May, my alma mater shared a Facebook post about emdee Skin. Within days, our user base grew from just a few thousand to over 70,000. One of the comments said, "I've been using the app for a year — it saved my mother’s life." That’s exactly why I started this project back in early 2018.

But we can’t bring emdee fully to market without regulatory approval from the FDA and the European Union. To do this, we need funding.

I’m asking for your help — to save lives: yours, mine, and those of our loved ones.
A single photo can save a life. Let’s make it happen — together.

Supporters

• 
  Mr. Alex Fair, MS
  06/15/2025 - Liked the project.

Comments

Updates

No updates found .